Stay up to date with notifications from The Independent

Notifications can be managed in browser preferences.

Abortion drugs trial succeeds

Celia Hall Medical Editor
Thursday 31 August 1995 18:02 EDT
Comments

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

CELIA HALL

Medical Editor

A new method of medical abortion using two drugs which are already licensed, has been tried successfully in the United States where opposition is preventing use of the "abortion pill" RU486.

The method involves small doses of a drug used for cancer, methotrexate, which stops cells dividing, and a prostaglandin, misoprostol, a hormone which stimulates contractions.

Of 178 women, the method was successful in 88 per cent who had abortions within 24 hours of taking the second drug and in 6 per cent after two doses of the prostaglandin.

The anti-abortion lobby in the US has been successful in delaying the licencing of RU486 (mifepristone). In Boston last December, two women were shot dead and six wounded when a gunman attacked an abortion clinic which was testing the drug. However, it is widely used in France and for about10,000 legal arbortions in the United Kingdom.

Writing in the the New England Journal of Medicine, Dr Richard Hausknecht, of the department of obstetrics, gynaecology and reproductive science, Mount Sinai School of Medicine, New York, says the new drug combination is effective, safe and easily implemented. He says it permits greater privacy and personal control for the woman.

Ruth Grigg, spokeswoman for the Family Planning Association, said the new method offered a potentially interesting alternative. "The drug stops the embryo in its tracks. The second drug clears out the womb. If it is a safe and effective method then women should have the opportunity to choose it."

Join our commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in